Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
SPORE in Prostate Cancer
Explore this Website
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
Home
About Us
Toggle About Us menu options
Affiliations
Donate
Resources
Job Opportunities
Contact Us
Research
Toggle Research menu options
Project 1
Project 2
Project 3
Project 4
Programs
Toggle Programs menu options
Career Enhancement Program
Toggle Career Enhancement Program menu options
2023 CEP Projects
Developmental Research Program
Toggle Developmental Research Program menu options
2023 DRP Awardee Projects
Cores
Toggle Cores menu options
Administrative Core
Biospecimen & Pathology
Computational Biology - Biostatistics
Investigators
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Research
Programs
Cores
Investigators
Publications
News
Home
Publications
Publications
Found 23 results
Author
Title
Type
Year
Filters:
Author
is
Sboner, Andrea
[Clear All Filters]
2021
Grbesa I
,
Augello MA
,
Liu D
,
McNally DR
,
Gaffney CD
,
Huang D
,
Lin K
,
Ivenitsky D
,
Goueli R
,
Robinson BD
et al.
. 2021.
Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity.
.
Cell Rep. 36(10):109625.
Brady NJ
,
Bagadion AM
,
Singh R
,
Conteduca V
,
Van Emmenis L
,
Arceci E
,
Pakula H
,
Carelli R
,
Khani F
,
Bakht M
et al.
. 2021.
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
.
Nat Commun. 12(1):3372.
Liu D
,
Augello MA
,
Grbesa I
,
Prandi D
,
Liu Y
,
Shoag JE
,
R Karnes J
,
Trock BJ
,
Klein EA
,
Den RB
et al.
. 2021.
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
.
J Clin Invest. 131(10)
2020
Beltran H
,
Nanus DM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
,
Tagawa ST
,
Demichelis F
,
Romanel A
,
Conteduca V
,
Casiraghi N
et al.
. 2020.
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
.
J Clin Invest. 130(4):1653-1668.
Barbieri CE
,
Sboner A
,
Liu D
,
Ben-Salem S
,
Hu Q
,
Liu Y
,
Alshalalfa M
,
Zhao X
,
Wang I
,
Venkadakrishnan VBalaji
et al.
. 2020.
Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes.
.
Eur Urol Open Sci. 22:34-44.
Liu D
,
Barbieri CE
,
Rubin MA
,
Demichelis F
,
Mosquera JMiguel
,
Elemento O
,
Sboner A
,
Shoag JE
,
Poliak D
,
Goueli RS
et al.
. 2020.
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.
.
Nat Commun. 11(1):1987.
Park K
,
Rubin MA
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
,
Tran H
,
Eng KW
,
Ramazanoglu S
,
Rolon RMMarrero
,
Scognamiglio T
et al.
. 2020.
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome.
.
Arch Pathol Lab Med. 144(12):1535-1546.
Rubin MA
,
Beltran H
,
Ballman KV
,
Sboner A
,
Cyrta J
,
Demichelis F
,
Augspach A
,
De Filippo MRosaria
,
Prandi D
,
Thienger P
et al.
. 2020.
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
.
Nat Commun. 11(1):5549.
Conteduca V
,
Beltran H
,
Nanus DM
,
Tagawa ST
,
Mosquera JMiguel
,
Sboner A
,
Elemento O
,
Ku S-Y
,
Puca L
,
Slade M
et al.
. 2020.
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.
.
Mol Cancer Ther. 19(5):1157-1164.
2019
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(4):603-617.e8.
Conteduca V
,
Oromendia C
,
Eng KW
,
Bareja R
,
Sigouros M
,
Molina A
,
Faltas BM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
et al.
. 2019.
Clinical features of neuroendocrine prostate cancer.
.
Eur J Cancer. 121:7-18.
Puca L
,
Gavyert K
,
Sailer V
,
Conteduca V
,
Dardenne E
,
Sigouros M
,
Isse K
,
Kearney M
,
Vosoughi A
,
Fernandez L
et al.
. 2019.
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
.
Sci Transl Med. 11(484)
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Gerke T
,
Beltran H
,
Wang X
,
Lee G-SMary
,
Sboner A
,
R Karnes J
,
Klein EA
,
Davicioni E
,
Yousefi K
,
Ross AE
et al.
. 2019.
Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
.
Cancer Epidemiol Biomarkers Prev. 28(3):584-590.
Berger A
,
Brady NJ
,
Bareja R
,
Robinson B
,
Conteduca V
,
Augello MA
,
Puca L
,
Ahmed A
,
Dardenne E
,
Lu X
et al.
. 2019.
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
.
J Clin Invest. 129(9):3924-3940.
2018
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer. 124(5):1008-1015.
Conteduca V
,
Sigouros M
,
Sboner A
,
Pritchard CC
,
Beltran H
. 2018.
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy.
.
JCO Precis Oncol. 2
Liu D
,
Takhar M
,
Alshalalfa M
,
Erho N
,
Shoag J
,
Jenkins RB
,
R Karnes J
,
Ross AE
,
Schaeffer EM
,
Rubin MA
et al.
. 2018.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer.
.
JCO Precis Oncol. 2018
Liu D
,
Takhar M
,
Alshalalfa M
,
Erho N
,
Shoag J
,
Jenkins RB
,
Karnes J
,
Ross AE
,
Schaeffer EM
,
Rubin MA
et al.
. 2018.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
.
JCO Precision Oncology.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Beltran H
,
Oromendia C
,
Danila DC
,
Montgomery B
,
Hoimes C
,
Szmulewitz RZ
,
Vaishampayan U
,
Armstrong AJ
,
Stein M
,
Pinski J
et al.
. 2018.
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
.
Clin Cancer Res.
Shoag J
,
Liu D
,
Blattner M
,
Sboner A
,
Park K
,
Deonarine L
,
Robinson BD
,
Mosquera JMiguel
,
Chen Y
,
Rubin MA
et al.
. 2018.
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
.
J Clin Invest. 128(1):381-386.
2017
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017